Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 7Gynecologic 5Head & Neck 2Gastrointestinal 2Genitourinary 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Breast Neoplasms 513Breast Neoplasms, Male 79Ovarian Neoplasms 54Triple Negative Breast Neoplasms 46Lung Neoplasms 43Colonic Neoplasms 41Prostatic Neoplasms 38Neoplasms 38Neoplasm Metastasis 35Carcinoma, Non-Small-Cell Lung 33Melanoma 31Pancreatic Neoplasms 29Colorectal Neoplasms 28Stomach Neoplasms 24Carcinoma, Ovarian Epithelial 24Endometrial Neoplasms 23Carcinoma, Renal Cell 23Inflammatory Breast Neoplasms 21Brain Neoplasms 20Carcinoma, Intraductal, Noninfiltrating 19Breast Carcinoma In Situ 19Rectal Neoplasms 18Urinary Bladder Neoplasms 17Lymphoma, Non-Hodgkin 17Lymphoma, T-Cell, Cutaneous 16Leukemia, Lymphocytic, Chronic, B-Cell 16Esophageal Neoplasms 16Uterine Cervical Neoplasms 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma 15

Interventions

trastuzumab deruxtecan 1ceralasertib 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Carcinosarcoma × Breast × Clear all
NCT04704661 2026-05-13

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

National Cancer Institute (NCI)

Phase 1 Active not recruiting
51 enrolled
BreastGastrointestinalGynecologicHead & NeckSarcoma

Breast Neoplasms, Carcinosarcoma, Colonic Neoplasms, Neoplasm Metastasis, Salivary Gland Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡